Social Media (#SoMe) has become a global phenomenon with more than 73% of adults actively engaged online. Specific to healthcare, these applications are being included with ever increasing frequency as a complement to both patient treatment and medical training. Furthermore, #SoMe has permitted medical innovators to transcend traditional limits and collaborate via methods previously unexplored. These platforms will only become more influential in the healthcare sector as more people around the world gain internet access.
The need to rehabilitate American infrastructure such as roads, bridges, and water systems is well recognized. These services are used daily by millions and impact the economy, health, and commerce of America. Likewise, primary care needs rehabilitation, investment, and much more public policy attention.
Vaccines can play a large role in promoting equity and reducing poverty. Researchers recently developed analytical methods to examine the potential distributional impact (across socioeconomic groups) and poverty reduction impact (decrease in the number of cases of medical impoverishment) of vaccines in low- and middle-income countries. Vaccines were found to have large pro-poor benefits: they could reduce health disparities in populations, as vaccine-preventable deaths averted would be more important among the lowest than among the highest socioeconomic groups; and, they could prevent a large number of cases of medical impoverishment, largely concentrated among the poorest socioeconomic groups. Vaccines could cost-effectively contribute to reducing health disparities and poverty in developing countries.
Not a day goes by currently without at least some mention of the current opioid crisis and seemingly never ending increases in heartbreaking overdose deaths. Although this tragedy has taken center stage receiving a fairly constant media spotlight, the opioid specific focus is occurring in the context of a broader enduring and endemic problem related to alcohol and other drug use disorders.
The names are many: embryoids, synthetic embryos, artificial embryos, embryo-like entities, but the central issues remain the same. Should we grow replicas of embryos in a dish? And if so, how exact is too exact?